Charles Schwab’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-853,475
Closed -$20.2M 3538
2023
Q4
$20.2M Buy
853,475
+54,920
+7% +$1.3M 0.01% 1592
2023
Q3
$11.9M Buy
798,555
+533,821
+202% +$7.96M ﹤0.01% 1823
2023
Q2
$2.9M Buy
264,734
+226,254
+588% +$2.48M ﹤0.01% 2437
2023
Q1
$336K Buy
38,480
+3,914
+11% +$34.1K ﹤0.01% 3059
2022
Q4
$217K Hold
34,566
﹤0.01% 3170
2022
Q3
$121K Sell
34,566
-14,046
-29% -$49.2K ﹤0.01% 3208
2022
Q2
$144K Sell
48,612
-190,603
-80% -$565K ﹤0.01% 3262
2022
Q1
$744K Buy
239,215
+59,256
+33% +$184K ﹤0.01% 2967
2021
Q4
$609K Buy
179,959
+6,000
+3% +$20.3K ﹤0.01% 3088
2021
Q3
$635K Sell
173,959
-357,375
-67% -$1.3M ﹤0.01% 3060
2021
Q2
$2.32M Sell
531,334
-7,780
-1% -$33.9K ﹤0.01% 2664
2021
Q1
$2.45M Buy
539,114
+19,421
+4% +$88.2K ﹤0.01% 2602
2020
Q4
$2.98M Sell
519,693
-725
-0.1% -$4.16K ﹤0.01% 2460
2020
Q3
$3.77M Buy
520,418
+84,488
+19% +$612K ﹤0.01% 2220
2020
Q2
$1.52M Buy
435,930
+60,665
+16% +$212K ﹤0.01% 2507
2020
Q1
$556K Buy
375,265
+5,561
+2% +$8.24K ﹤0.01% 2676
2019
Q4
$725K Sell
369,704
-21,394
-5% -$42K ﹤0.01% 2698
2019
Q3
$2M Sell
391,098
-2,025
-0.5% -$10.4K ﹤0.01% 2376
2019
Q2
$2.82M Buy
393,123
+28,205
+8% +$202K ﹤0.01% 2241
2019
Q1
$4.85M Buy
364,918
+41,319
+13% +$549K ﹤0.01% 1990
2018
Q4
$2.55M Sell
323,599
-2,052
-0.6% -$16.2K ﹤0.01% 2237
2018
Q3
$3.61M Buy
325,651
+195,486
+150% +$2.17M ﹤0.01% 2212
2018
Q2
$1.75M Buy
130,165
+109,800
+539% +$1.47M ﹤0.01% 2416
2018
Q1
$265K Buy
20,365
+7,900
+63% +$103K ﹤0.01% 2911
2017
Q4
$115K Buy
+12,465
New +$115K ﹤0.01% 3024